MedPage Today on MSN
Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
While liver stiffness measurement by vibration-controlled transient elastography with a 25 kPa threshold might detect CSPH, the overall low quality of the studies means that these results are not very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results